INTRODUCTION: Three randomized trials have demonstrated that @entity8447 ( @entity8447 ) radiotherapy decreases biochemical relapse for those with adverse pathology. Our purpose was to describe the incidence of pathologic risk factors for recurrence in a contemporary series of @entity1 treated with @entity8447 and to describe the use of post- @entity8447 radiotherapy. METHODS: All incident @entity263 diagnosed between January 2005 and December 2007 were identified from the @entity5 registry. Cases were then linked to radiotherapy records which included dose and modality (external beam radiotherapy and brachytherapy). The pathology reports in the @entity5 registry were reviewed for pathologic stage, grade and margin status. RESULTS: We identified 9223 @entity1 with @entity263 . Overall, 36.3% of @entity1 treated with @entity8447 had positive margins, and may have benefited from adjuvant radiotherapy. After @entity8447 , 332 (15%) @entity1 had radiotherapy to the prostate bed; of these, only 25 (1.1%) received truly adjuvant radiotherapy (delivered within 6 months with a prostate-specific antigen of <0.2 ng/mL). Of the 2181 @entity1 treated with @entity8447 , 270 (12%) were seen by a radiation oncologist within 6 months of @entity8447 . Of the 1015 @entity1 (47%) with adverse @entity8447 pathology (positive margins, extracapsular extension or seminal vesicle invasion), 230 (23%) were seen by a radiation oncologist within 6 months of @entity8447 . CONCLUSION: Not all @entity1 with adverse prostatectomy pathology were seen by a radiation oncologist post-prostatectomy, and very few received adjuvant radiotherapy despite almost half of them having risk factors for relapse.

The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for @entity1 with XXXX in British Columbia.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity8447 :: ('MESH:D017169', 'Disease') :: ['post-radical prostatectomy', 'RP'] @entity263 :: ('MESH:D011471', 'Disease') :: ['prostate cancers', 'prostate cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumour']
@entity263 :: (MESH:D011471,Disease) :: ['prostate cancer']
